Acadia Pharmaceuticals buy Needham & Company LLC
Start price
24.01.24
/
50%
€24.80
Target price
24.01.25
€33.86
Performance (%)
-45.20%
Price
20.05.24
€13.74
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL for Acadia Pharmaceuticals is performing very badly with a performance of -45.20%. This prediction currently runs until 24.01.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -2.380% | -2.380% |
| iShares Core DAX® | 0.051% | 5.593% |
| iShares Nasdaq 100 | 1.808% | 7.445% |
| iShares Nikkei 225® | 2.181% | 2.815% |
| iShares S&P 500 | 1.040% | 4.975% |
Comments by Needham___Company_LL for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $37.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Needham___Company_LL for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.02
09.05.24
09.05.24
€27.88
09.05.25
09.05.25
-8.49%
20.05.24
20.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.56
09.04.24
09.04.24
€29.40
09.04.25
09.04.25
-17.91%
20.05.24
20.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.20
12.03.24
12.03.24
€29.32
12.03.25
12.03.25
-24.51%
20.05.24
20.05.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.60
28.02.24
28.02.24
€33.24
28.02.25
28.02.25
-36.39%
20.05.24
20.05.24